Kodiak Sciences (KOD) EBIT (2017 - 2026)
Kodiak Sciences (KOD) reported EBIT of -$59.8 million for Q1 2026, down 1.19% on a YoY basis from -$60.5 million in Q1 2025, and down 4.05% quarter-over-quarter from -$57.5 million in Q4 2025.
Kodiak Sciences (KOD) EBIT (2017 - 2026) Analysis & Trends
Kodiak Sciences has reported EBIT for 10 years, with the latest figure at -$59.8 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT fell 1.19% year-over-year to -$59.8 million; the trailing twelve-month figure through Mar 2026 stood at -$235.1 million (down 17.62% YoY), and the FY2025 full-year result was -$234.4 million, down 25.44% from the prior year.
- EBIT for Q1 2026 stood at -$59.8 million, down from -$57.5 million in the prior quarter.
- The five-year high for EBIT was -$46.1 million in Q1 2024, with the low at -$95.8 million in Q1 2022.
- Historically, EBIT has averaged -$64.7 million across 5 years, with a median of -$59.8 million in 2026.
- Annual changes were most pronounced in 2022 — EBIT tumbled 89.42% — and 2024, when it surged 43.44%.
- Kodiak Sciences' EBIT stood at -$74.1 million in 2022, then gained by 14.44% to -$63.4 million in 2023, then gained by 27.13% to -$46.2 million in 2024, then decreased by 24.41% to -$57.5 million in 2025, then decreased by 4.05% to -$59.8 million in 2026.
- The last three EBIT figures came in at -$59.8 million (Q1 2026), -$57.5 million (Q4 2025), and -$62.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -65.83 Mn |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | -59.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.78 Mn |
| Dec 31, 2025 | -57.45 Mn |
| Sep 30, 2025 | -62.35 Mn |
| Jun 30, 2025 | -55.51 Mn |
| Mar 31, 2025 | -59.07 Mn |
| Dec 31, 2024 | -46.18 Mn |
| Sep 30, 2024 | -46.63 Mn |
| Jun 30, 2024 | -47.98 Mn |
| Mar 31, 2024 | -46.06 Mn |
| Dec 31, 2023 | -63.37 Mn |
| Sep 30, 2023 | -54.50 Mn |
| Jun 30, 2023 | -84.83 Mn |
| Mar 31, 2023 | -74.62 Mn |
| Dec 31, 2022 | -74.07 Mn |
| Sep 30, 2022 | -79.48 Mn |
| Jun 30, 2022 | -92.07 Mn |
| Mar 31, 2022 | -95.77 Mn |
| Dec 31, 2021 | -93.05 Mn |
| Sep 30, 2021 | -67.54 Mn |
| Jun 30, 2021 | -55.91 Mn |